Nephros (NEPH) Current Leases (2019 - 2020)
Nephros (NEPH) posted Current Leases of $332000.0 for Q4 2020, up 1.84% on a QoQ basis from $326000.0 in Q3 2020, and up 26.72% year-over-year from $262000.0 in Q1 2020.
Powered by 
Analysis
Nephros (NEPH) Current Leases (2019 - 2020) Analysis & Trends
Nephros has reported Current Leases for 2 years, with the latest figure at $332000.0 in Q4 2020.
- On a quarterly basis, Current Leases rose 26.72% year-over-year to $332000.0 in Q4 2020; TTM through Dec 2020 was $332000.0, a 26.72% increase from a year earlier, with the FY2020 full-year figure at $332000.0, up 26.72% from the prior year.
- Current Leases was $332000.0 for Q4 2020 at Nephros, up from $326000.0 in the prior quarter.
- The five-year high for Current Leases was $332000.0 in Q4 2020, with the low at $191000.0 in Q1 2019.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 178.01 Bn | 172.41 Bn | 7.27 Bn | - |
| 2 | Intuitive Surgical | 131.29 Bn | 126.08 Bn | 1.96 Bn | - |
| 3 | Medtronic | 116.38 Bn | 107.56 Bn | 6.34 Bn | - |
| 4 | Stryker | 106.01 Bn | 102.53 Bn | 4.50 Bn | - |
| 5 | Boston Scientific | 63.40 Bn | 62.86 Bn | 3.85 Bn | - |
| 6 | Edwards Lifesciences | 48.89 Bn | 44.64 Bn | 1.35 Bn | 24.10 Mn |
| 7 | Alcon | 32.59 Bn | 31.13 Bn | 1.68 Bn | 81.00 Mn |
| 8 | Dexcom | 31.84 Bn | 29.89 Bn | 830.00 Mn | 20.70 Mn |
| 9 | Steris | 20.61 Bn | 20.13 Bn | 684.20 Mn | 35.60 Mn |
| 10 | Nephros | 48.31 Mn | 43.62 Mn | 4.03 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2020 | 332,000.00 |
| Sep 30, 2020 | 326,000.00 |
| Jun 30, 2020 | 315,000.00 |
| Mar 31, 2020 | 312,000.00 |
| Dec 31, 2019 | 262,000.00 |
| Sep 30, 2019 | 251,000.00 |
| Jun 30, 2019 | 223,000.00 |
| Mar 31, 2019 | 191,000.00 |